US Consumer Marketing Senior Manager, VELSIPITY (Secondment 12 Months)

WHY PATIENTS NEED YOU

The US Velsipity Team is a highperforming missiondriven group within Pfizers Specialty Care / RHU/GI organization united by a shared ambition to transform care for patients living with moderate to severe ulcerative colitis. As a priority brand and one of Pfizers most visible launches Velsipity brings together a diverse mix of Consumer HCP Health Equity Medical Education Field Readiness Omnichannel and Insights experts who collaborate closely to deliver bold insightled work.

Led by Stephanie Harvell as Velsipity Lead and anchored by dedicated Consumer and HCP subteams the group embodies a culture of creativity speed and operational excellence. Key leadership roles include the Velsipity Consumer Lead (Shannon Lia-Onay) and HCP Lead (Andrew Cole).

WHAT YOU WILL ACHIEVE

Across all functions the Velsipity team is known for:

• A bold innovative mindset that embraces new channels and Pfizer Firsts

• Tight crossfunctional integration ensuring a seamless patient and HCP experience

• High standards for excellence grounded in data insights and rigorous RC partnership

• A collaborative inclusive culture that invests heavily in people development and team connectedness (the team includes numerous Marketing Rotational Program alumni)

Joining the Velsipity team means stepping into a highvisibility fastmoving brand environment where you can directly shape the trajectory of a major growth brand elevate UC care and contribute to a collaborative ambitious and supportive marketing organization making a real impact for patients.

HOW YOU WILL ACHIEVE IT

Disease and Product Information:

Ulcerative colitis (UC) is a chronic inflammatory condition of the large intestine characterized by persistent inflammation bowel urgency abdominal pain rectal bleeding and unpredictable flareups. As an autoimmune disease UC can significantly impact daily life affecting a patients comfort confidence and longterm health. Many patients cycle through multiple therapiessuch as 5ASAs steroids immunomodulators JAK inhibitors or biologicsbefore finding adequate relief.

Velsipity (etrasimod) is Pfizers oncedaily oral S1P receptor modulator approved for adults with moderately to severely active UC. Unlike biologic therapies that require injections or infusions Velsipity offers patients a convenient oral option designed to help reduce inflammation in the gut by preventing certain immune cells from migrating to the intestines. Clinical trials have shown meaningful improvements in symptoms including reductions in bathroom urgency rectal bleeding and overall disease severity with some patients achieving clinical remission as early as 12 weeks.

Positioned as a firstline advanced therapy option for appropriate patients Velsipity combines a strong efficacy profile with a favorable safety profile making it an important treatment choice for individuals seeking a nonbiologic alternative. As a rapidly growing brand within Pfizers Inflammation & Immunology portfolio Velsipity plays a key role in transforming the UC treatment landscape and improving the lives of patients managing this challenging chronic condition. Velsipity was FDA-approved in October 2023.

For the 12-month secondment the secondee will be working on several high-impact projects to help achieve the goal of growing Velsipitys share of first-line advanced therapy treatment options by motivating consumers to feel comfortable stepping up from conventional therapy to advanced therapy and requesting an oral option.

Project Description:

It is an exciting time to join the Velsipity Consumer Team with development of a new branded creative campaign underway and a planned launch at the end of Q2. As part of the campaign launch preparation the secondee will lead the endtoend development and execution of critical consumer initiatives owning key elements of the omnichannel activation. This includes ensuring seamless pullthrough of the new creative platform into a cohesive highimpact experience across priority channels such as the website point of care patient education (print) and preinitiation touchpoints.

The branded website is a critical engine of the consumer experience and this role will play a central part in shaping its future.

• Bring the new consumer campaign to life across the sitetranslating headlines visuals claims and calls to action into a seamless onbrand digital experience

• Define the strategy structure and content vision for a potential Patient Ambassador Hub

• Refresh accessrelated messaging to reflect the latest coverage affordability and pullthrough guidance

• Lead the endtoend migration of the branded siteto Zenith partnering closely with agency and internal teams to ensure a smooth transition with minimal disruption

This role also offers a unique opportunity to lead execution of the For Me campaign simplifying the VelsipityForMe program through clear patientcentric messaging that highlights benefits reduces initiation barriers and drives enrollment across website social and pointofcare channels. This includes activating a cohesive omnichannel plan by developing and optimizing assets integrating real patient insights and partnering crossfunctionally to improve engagement understanding and overall program uptake. Additionally the secondee will partner with the HCP and Access teams to optimize communication of required testing at or near the start of treatment.

QUALIFICATIONS

Must-Have

• BA/BS with 6 years of experience or MBA/MS with 5 years of experience.

• Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers develop and coach others oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.

Nice-to-Have

• Prior consumer marketing experience is strongly preferred

• PhD or JD with 1 years of experience.

OTHER JOB DETAILS

• Last Date to Apply for Job:March 26 2026.

• Additional Location Information:USA - PA - Collegeville / Any US Pfizer Remote

• Eligible for Relocation Package NO

• Secondment 12 months

• If you are currently in a driving position with a fleet vehicle and this secondment does not require driving as an essential function of the position for12 months or longer you will be required to turn in your fleet vehicle for the duration of the non-driving secondment. Please refer to the Fleet Policy and Procedures document for more information.

• There will be no change to your current work location.

• Position is considered Flexible and colleagues are expected to comply with Log In For Your Day(LIFYD) requirements at site location (e.g. about 2.5 days a week in office).

• Note: This secondment offers a valuable opportunity for professional growth. It will need to be funded by the secondees home market.

• Beyond campaign execution the secondee will also serve as budget captain and act as the Sales LT/Field Force Liaison for the consumer team.

• NON-STANDARD WORK SCHEDULE TRAVEL OR ENVIRONMENT REQUIREMENTS: travel up to 10% - 15%

Relocation assistance may be available based on business needs and/or eligibility.

Candidates must be authorized to be employed in the U.S. by any employer.

U.S. work visa sponsorship (such as TN O-1 H-1B etc.) is not available for this role now or in the future.